A multicenter, placebo-controlled, double-blind, multiple-crossover study of Fentanyl Pectin Nasal Spray (FPNS) in the treatment of breakthrough cancer painRussell K. Portenoy, Donald R. Taylor, Allen W. Burton et al.|Pain|2010Cited by 155
Impact of Breakthrough Pain on Quality of Life in Patients with Chronic, Noncancer Pain: Patient Perceptions and Effect of Treatment with Oral Transmucosal Fentanyl Citrate (OTFC<sup>®</sup>, ACTIQ<sup>®</sup>)Donald R. Taylor, Steven A. Shoemaker, Jeffrey Reinking et al.|Pain Medicine|2007Cited by 42
Letter to the Editor: Pharmacokinetics of Non-Intravenous Formulations of FentanylDonald R. Taylor, L. M. Torres, Allen W. Burton et al.|Clinical Pharmacokinetics|2013Cited by 0